{
    "2020-12-04": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Novartis announces first data from REACH3 trial showing JakaviÂ® (ruxolitinib) significantly improved outcomes in patients with steroid-resistant/dependent chronic GvHD",
                "features": {
                    "keywords": [
                        "Novartis",
                        "REACH3 trial",
                        "Jakavi",
                        "ruxolitinib",
                        "improved outcomes",
                        "steroid-resistant/dependent",
                        "chronic GvHD"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "New Results on Blood Disorder Treatments Are Coming. Watch These Stocks.",
                "features": {
                    "keywords": [
                        "Blood Disorder",
                        "Treatments",
                        "Results",
                        "Stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}